Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × Docetaxel × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 20 Prostatic Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 9 Stomach Neoplasms 6 Lung Neoplasms 6 Urinary Bladder Neoplasms 5 Neoplasms 5 Carcinoma, Transitional Cell 5 Breast Neoplasms 5 Prostatic Neoplasms, Castration-Resistant 4 Non-Muscle Invasive Bladder Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Neoplasm Metastasis 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Squamous Cell 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Sarcoma 2 Oropharyngeal Neoplasms 2 Nasopharyngeal Carcinoma 2 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 2 HER2-positive Breast Cancer 2 Advanced Solid Tumors 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1

Interventions

Carboplatin 2 Bevacizumab 2 selpercatinib 1 selinexor 1 repotrectinib 1 relatlimab 1 relacorilant 1 pembrolizumab 1 olaparib 1 elacestrant 1 durvalumab 1 darolutamide 1 abemaciclib 1 Sunitinib 1 RAD1901 1 Pluvicto 1 Pemetrexed 1 Nivolumab 1 Immunotherapy 1 Drug Therapy 1 Cisplatin 1 Cetuximab 1 Abiraterone Acetate 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 130-nm albumin-bound paclitaxel 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡